BioCentury
ARTICLE | Financial News

arGEN-X planning Euronext IPO

June 11, 2014 12:25 AM UTC

arGEN-X B.V. (Rotterdam, the Netherlands) announced plans for an IPO on NYSE Euronext. KBC Securities and Kempen are joint global coordinators and joint bookrunners; Petercam is co-lead manager and Wedbush PacGrow Life Sciences is the selling agent. The company said details will be available in "a couple of weeks" and a listing is expected in early summer, if successful. ...